Jot Dx
Payments companies reported to CMS as associated with Jot Dx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jot Dx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jot Dx
These are the largest totals companies reported as associated with Jot Dx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Perino | Stanford, CA | Clinical Cardiac Electrophysiology | $4,305.06 |
| Russell Canham | Dallas, TX | Clinical Cardiac Electrophysiology | $2,697.37 |
| Suleyka Olivero-Rivera | Bayamon, PR | Clinical Cardiac Electrophysiology | $2,135.22 |
| Kasey Gildersleeve | Houston, TX | Neurology (Psychiatry & Neurology) | $2,000.00 |
| James Lally | Las Vegas, NV | Interventional Cardiology | $1,918.09 |
| Richard Charney | New Rochelle, NY | Cardiovascular Disease | $1,798.95 |
| Joven Dungo | Jersey City, NJ | Cardiovascular Disease | $1,673.29 |
| Leon Varjabedian | Las Vegas, NV | Interventional Cardiology | $1,550.52 |
| Adam Roberts | Rockville Centre, NY | Medical | $1,513.75 |
| Howard Tarkin | Cortlandt Manor, NY | Cardiovascular Disease | $1,462.31 |
Prescribed Jot Dx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.